Recent Activity

Loading...

ABCL

AbCellera Biologics, Inc. · NASDAQ

Performance

+1.59%

1W

-11.52%

1M

-21.79%

3M

-12.73%

6M

-32.75%

YTD

-32.75%

1Y

Profile

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Investment Analysis Report: ABCL

Overview

ABCL is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $1.55 billion. In this report, we will conduct a comprehensive analysis of ABCL's financial statements over the past three years, focusing on the Balance She...

See more ...

Technical Analysis of ABCL 2024-05-03

Overview:

In analyzing the technical indicators for ABCL stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim t...

See more ...

Recent News & Updates